CBIO vs ABBV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CBIO

46.8
AI Score
VS
CBIO Wins

ABBV

41.4
AI Score

Investment Advisor Scores

CBIO

47score
Recommendation
HOLD

ABBV

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO ABBV Winner
Revenue 1.04M 8.24B ABBV
Net Income -48.12M 2.75B ABBV
Net Margin -4631.4% 33.4% ABBV
Operating Income -51.09M 8.82B ABBV
ROE -29.5% -94.0% CBIO
ROA -26.3% 4.2% ABBV
Total Assets 182.76M 66.16B ABBV
Cash 171.59M 8.02B ABBV
Current Ratio 9.66 1.20 CBIO
Free Cash Flow -28.56M 9.52B ABBV

Relative Price Performance (Last 90 Days)

CBIO 1M: +0.7% · 3M: -15.2% ABBV 1M: +3.1% · 3M: +23.5%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

ABBV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 64

RSI (14): 64.1 · Price: $264.96

Fundamentals Snapshot

Metric CBIO ABBV
Market Cap
Forward P/E -6.5 16.3
Trailing P/E 75.2
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.7%
Operating Margin -14.3% 0.4%
EPS -0.13 3.48
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.